These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 35789548)
1. Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma. Xiao W; Tang P; Sui Z; Han Y; Zhao G; Wu X; Yang Y; Zhu N; Gong L; Yu Z; Zhang H Cancer Med; 2023 Jan; 12(2):2117-2133. PubMed ID: 35789548 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J Front Immunol; 2021; 12():669750. PubMed ID: 34054840 [TBL] [Abstract][Full Text] [Related]
3. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer. Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y Front Immunol; 2023; 14():1199040. PubMed ID: 37313409 [TBL] [Abstract][Full Text] [Related]
4. A novel fatty acid metabolism-related signature identifies MUC4 as a novel therapy target for esophageal squamous cell carcinoma. Li S; Liu Z; Chen Q; Chen Y; Ji S Sci Rep; 2024 May; 14(1):12476. PubMed ID: 38816411 [TBL] [Abstract][Full Text] [Related]
5. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
6. VBP1 promotes tumor proliferation as a part of the hypoxia-related signature in esophageal squamous cell carcinoma. Miao H; Gao W; Zhong L; Li H; Chen D; Xu C; Wen Z; Chen Y Hum Cell; 2024 Jul; 37(4):1141-1155. PubMed ID: 38700744 [TBL] [Abstract][Full Text] [Related]
7. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma. Zhang D; Zhao F; Li J; Qin X; Li S; Niu R Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of an autophagy-related gene signature for predicting prognosis in patients with esophageal squamous cell carcinoma. Shi X; Li Y; Pan S; Liu X; Ke Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H Sci Rep; 2022 Feb; 12(1):1960. PubMed ID: 35121801 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
10. Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma. Lian L; Teng SB; Xia YY; Shen XM; Zheng Y; Han SG; Wang WJ; Xu XF; Zhou C J Gastrointest Oncol; 2022 Apr; 13(2):462-477. PubMed ID: 35557566 [TBL] [Abstract][Full Text] [Related]
11. Construction of a Novel Mitochondria-Associated Gene Model for Assessing ESCC Immune Microenvironment and Predicting Survival. Wang X; Zhang Z; Shi Y; Zhang W; Su C; Wang D J Microbiol Biotechnol; 2024 May; 34(5):1164-1177. PubMed ID: 38719775 [TBL] [Abstract][Full Text] [Related]
12. A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma. Guo D; Zhang X; Du X; Yao W; Shen W; Zhu S BMC Med Genomics; 2023 Feb; 16(1):27. PubMed ID: 36803971 [TBL] [Abstract][Full Text] [Related]
13. Identification of prognostic value of anoikis-related gene score model combined with tumor microenvironment score models in esophageal squamous cell carcinoma. Zhang M; Liang Y; Song P J Gene Med; 2024 Jan; 26(1):e3624. PubMed ID: 38087999 [TBL] [Abstract][Full Text] [Related]
14. Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma. Wang Y; Song T; Li K; Liu H; Han Y; Xu T; Cao F; Li Y; Yu Y World J Surg Oncol; 2022 Jul; 20(1):236. PubMed ID: 35840985 [TBL] [Abstract][Full Text] [Related]
15. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma. Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142 [TBL] [Abstract][Full Text] [Related]
16. Identification and validation of a prognostic signature of cuproptosis-related genes for esophageal squamous cell carcinoma. Zhang Y; Chen K; Wang L; Chen J; Lin Z; Chen Y; Chen J; Lin Y; Xu Y; Peng H Aging (Albany NY); 2023 Sep; 15(17):8993-9021. PubMed ID: 37665670 [TBL] [Abstract][Full Text] [Related]
17. A more novel and robust gene signature predicts outcome in patients with esophageal squamous cell carcinoma. Ma C; Luo H Clin Res Hepatol Gastroenterol; 2022 Dec; 46(10):102033. PubMed ID: 36265781 [TBL] [Abstract][Full Text] [Related]
18. Risk model based on genes regulating the response of tumor cells to T-cell-mediated killing in esophageal squamous cell carcinoma. Zhang X; Yu C; Zhou S; Zhang Y; Tian B; Bian Y; Wang W; Lin H; Wang LW Aging (Albany NY); 2024 Feb; 16(3):2494-2516. PubMed ID: 38305770 [TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma. Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127 [TBL] [Abstract][Full Text] [Related]
20. Development of a prognostic nomogram based on an eight-gene signature for esophageal squamous cell carcinoma by weighted gene co-expression network analysis (WGCNA). Xie J; Yang P; Wei H; Mai P; Yu X Ann Transl Med; 2022 Jan; 10(2):88. PubMed ID: 35282133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]